Home » Tonix PK Study Confirms Effectiveness of TNX-102 Sublingual Tablet
Tonix PK Study Confirms Effectiveness of TNX-102 Sublingual Tablet
Tonix Pharmaceuticals has completed dosing and plasma analysis of a pharmacokinetic (PK) study of its TNX-102 sublingual tablet, a formulation of cyclobenzaprine for bedtime use.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May